by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros

Slides:

Advertisements

Similar presentations

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):

Advertisements

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.

EBV-positive diffuse large B-cell lymphoma of the elderly by Chi Young Ok, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young Blood Volume 122(3):

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee,

Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3) Pathway in Multiple Myeloma Leticia Quintanilla-Martinez, Marcus Kremer, Katja.

PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal Cancers Xiao-Ping Zhou, Anu.

Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent.

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.

Pathway analysis of primary central nervous system lymphoma

Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis.

EBV DNA: a Hodgkin lymphoma biomarker?

Defects in DBA: more than meets the eye

by Yoko Otake, Sridharan Soundararajan, Tapas K. Sengupta, Ebenezer A

Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,

Deregulated expression of the Myc cellular oncogene drives development of mouse “Burkitt-like” lymphomas from naive B cells by Delin Zhu, Chen Feng Qi,

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Rituximab-induced tumor cell agglutination

CD3−CD56+ Non-Hodgkin's Lymphomas With an Aggressive Behavior Related to Multidrug Resistance by Bernard Drénou, Thierry Lamy, Laurence Amiot, Olivier.

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)‏ by Nicolas.

Nonmyeloablative conditioning for relapsed follicular lymphoma

by Gail Dallalio, Erin Law, and Robert T. Means

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster.

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells by Lin Qiu, Raymond Lai, Quan Lin, Esther.

Gastroesophageal tumor embolization to the popliteal arteries

Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.

Deep mining of the RBC proteome

Lymphomas Expressing ALK Fusion Protein(s) Other Than NPM-ALK

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,

AIDS-Related Extranodal Non-Hodgkin's Lymphomas With Plasma Cell Differentiation by Antonino Carbone, Annunziata Gloghini, Vincenzo Canzonieri, Umberto.

by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK–positive.

Blood Volume 92(10): November 15, 1998

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Detection of Normal and Chimeric Nucleophosmin in Human Cells

by Huifei Liu, and Shafinaz Hussein

BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

by Sara Tedoldi, Jennifer C

Latest lymphoma classification is skin deep

Lymphoma spread? Target CD47-SIRPα!

C-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma by Mauricio P. Oyarzo, L. Jeffrey Medeiros, Coralyn Atwell, Marianna.

A. glioblastoma with high (+++) KIT protein expression.

The summary page for cancer profiles.

Arnaud Uguen, MD, PhD Journal of Thoracic Oncology

MYC DNA is structurally abnormal and MYC protein is overexpressed in MCL cells. MYC DNA is structurally abnormal and MYC protein is overexpressed in MCL.

Quiz Page November 2006 American Journal of Kidney Diseases

NICD1 immunohistochemical staining in normal and tumor tissue.

A case of lenalidomide-dependent myelodysplastic syndrome

SIRT1 is downregulated in human gastric cancer (GC).

Optimal Proliferation of a Hematopoietic Progenitor Cell Line Requires Either Costimulation With Stem Cell Factor or Increase of Receptor Expression That.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

A-N: Immunofluorescence analysis of Bcl family genes in human islets of Langerhans. A-N: Immunofluorescence analysis of Bcl family genes in human islets.

Sickle cells and sickle trait in thrombosis

PD-L1 and tumor-associated macrophages in de novo DLBCL

Histopathology and bcl-2 immunohistochemistry of in situ follicular lymphoma.(A-B) Low-power view of H&E-stained (A) and bcl-2–stained (B) sections showing.

Photomicrograph of the tumor shows the chordoid meningioma with eosinophilic vacuolated tumor cells (large arrow) in a mucous-rich matrix (small arrow)

Resistance mechanism for ibrutinib in marginal zone lymphoma

Biology and treatment of Richter syndrome

Rituximab immunotherapy: it’s getting personal

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.

How I treat early-relapsing follicular lymphoma

A, cellular uptake of AS1411 in MCF-7 and MCF-10A cells.

This nasal inflammatory myofibroblastic tumor is composed of a storiform array of plump spindle cells with a background of chronic inflammatory infiltrate.

by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal

Cold agglutinin disease

Outcomes in patients with PTCL

Presentation transcript:

by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros BCL-3 overexpression in anaplastic lymphoma kinase–positive anaplastic large cell lymphoma by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros Blood Volume 102(3):1146-1147 August 1, 2003 ©2003 by American Society of Hematology

Expression of BCL-3 protein in systemic ALCL tumors. Expression of BCL-3 protein in systemic ALCL tumors. (A) An ALK-positive ALCL tumor with strong nuclear immunoreactivity in almost all tumor cells. (B) An ALK-negative ALCL tumor with relatively weaker nuclear immunoreactivity in many tumor cells. (Immunoperoxidase, DAB, hematoxylin counterstain, original magnification × 400.)‏ George Z. Rassidakis et al. Blood 2003;102:1146-1147 ©2003 by American Society of Hematology